Financial Results for the quarter ended 30.06.2026

To Date: 13.08.2026 BSE Limited P.J Towers Dalal Street Mumbai – 400001 Dear Sir, Sub: Outcome of board meeting under regulations 30 read with 33 (3) of SEBI (Listing Obligations and Disclosure requirements) regulations, 2015 Ref: Sangam Health Care Products Ltd (BSE Scrip Code: 531625) With reference to the subject cited, this is to inform the Exchange that at the Board meeting of M/s. Sangam Health Care Products Limited held on Thursday, the 13th day of August, 2026, at 4.00 P.M. at the registered office of the Company, the Company the following were duly considered and approved by the Board: 1. Un Audited Financial results for the quarter ended 30.06.2026 (enclosed). 2. Limited Review Report for the quarter ended 30.06.2026 (enclosed). 3. Re Appointment of Mr. Bhagat Reddy Dundumulla as Managing Director of the Company for a further period of five (5) years with effect from September 05, 2026, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company 4. Recommendation for the approval of members regarding the reappointment of Mrs. Padma Ghanakota (DIN: 07078176), who retires by rotation and, being eligible, has offered herself for reappointment. 5. Approval of the AGM Notice and Director's Report for the year ended March 31, 2026 along with Annexures thereto. 6. To convene the 32nd AGM of the members of the Company on Wednesday, 30 September 2026, at 9:00 AM. at the Registered Office: Survey No. 182, Yellampet Village, Medchal Mandal, Medchal District, Telangana — 501401. 7. The Register of Members and Share Transfer Books of the company will remain closed from 24.09.2026 to 30.09.2026 (both days inclusive) pursuant to regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting of the Board of Directors commenced at 4.00 P.M.(IST) and concluded at 5.15 P.M. (1ST) This is for the information and records of the Exchange, please. Thanking you. Yours truly, For Sangam Health Care Products Limited D. Bhagat Reddy Managing Director DIN: (07087331) [Details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with clause 7 of Para A of Annexure I of SEBI Circular dated November 11, 2024] Re-appointment of Managing Director Si. No. Particulars Details 1. Reason for change viz., Re-appointment of Mr. Bhagat Reddy appointment, resignation, Dundumulla as an Managing Director of the removal, death or otherwise Company. 2. Date appointment Re-appointment as Managing Director of the Company w.e.f. September 05, 2026 3. Terms of appointment Re-appointed as Managing Director of the Company for a further period of five (5) years with effect from September 5, 2026, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. 4. Brief profile Mr. Bhagat Reddy Dundumulla is already acting as Managing Director of the Company. He has 12 Years of Experience in manufacturing IV sets and other Medical Disposables 5. Disclosure of relationships Mr. Bhagat Reddy Dundumulla is not related between directors (in case of to any Director of the Company. appointment of a director) 6. No. of Shares held in the 2,00,000 Company 7. Information as required Mr. Bhagat Reddy Dundumulla is not pursuant to BSE Circular with debarred from holding the office of Director ref. no. LIST/COMP/14/2018-19 by virtue of any order passed by the and NSE Circular with ref. no. Securities and Exchange Board of India or NSE/CML/2018/24 dated June any other such authority. 20, 2018 For Sangam Health Care Products Limited D. Bhagat Reddy Managing Director DIN: (07087331) GROUD> SANGAM HEALTHCARE PRODUCTS LTD. Safti (ISO Certified Company) (CIN: L24230TG1993PLC016731) SANGAM HEALTH CARE PRODUCTS LIMITED 182, Yellampet village, Medchal Mandal, Hyderabad, Telangana-501401 UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 e (Rs,In Lakhs) Particulars ) Quarter ended Year Ended 30.06-202 31-03.2026 | 30-06-2025 | 31.03-2026 Un-Audited Audited Un-Audited [ Audited 1 |Income from Operations (a) [Net Sales/Income from Operations 302.56 265.50 281.67 12333 (b) |Other Income- 2,10 Total Income 302.56 267.60 281.67 1,125.43 2 |Expenditure (a) Cost of Raw material consumed 148.89) 100.96 166.21 (b) Purchase of stock-in-trade (c) Change in inventories of ished Goods Works-in Progress and Stock in Trade (d) Employees Benefit Expenses 61.98 107.21 10,89 (¢) Finance Cost 0.21 0.37 0.02 091 (e). Depreciation and Amortization Expenses 1 1.87 26 5,64 /(0. Other Expenditure 47.13| 10458 62.80 277.90 Total Expenses 259.65 314.99 271.17 | 1,104.72 3 [Profit from Operations before Extraordinary Items and Exceptional Items (1-2) (47.39) 10.49 | 20.71 4 |Exceptional Items Profit / (Loss) from Ordinary |Activities before tax (7+8) 42.91 (47.39) 10.49 Tax expense: | 10 |Current tax 11.16 3.82 2 Deferred tax 1.13 (23.32)| (2.49) 10.00 11 [Net Profit (+)/Loss(-) from Ordinary Activities 30.63 (27.89) 10.26 | 5.33 After Tax (9-10) 12 |Paid up equity share capital (no of shares) 1486.07 1486.07 1486,07 o |(face value of the share Rs.10/-) 14 |Earning Per Share (EPS) - a) Basic and diluted Eps before Extraordinaary 0.02 0.19 dioi o b) Basic and diluted Eps after Extraordinary 0.02 0,19 ob1 oA Note : 1 The above results were reviewed by the Audit Committee and taken on record by the Board of Directors at the meeting held on 13 y 08-2026 ° 2 The Limited Review of the Financials has been carried out by the Statutory Auditors of the Company in terms of of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 3 Previoiis Aécounting period's figures have been grouped/ regrouped wherever considered necessary For Sany Limited Place: Hyderdba&d Mfli:opfl Date: 13.08-2026., Managing m(;;c s DIN:017129 Survey No:-182 Yellampet Village, Medchal Mandal, Medchal Malkangiri Dist, Telangana -501 401 INDIA Eman;mau(eging,sangam@gmall.cam www.sangamheal 2.CO. Phone.: +91- 7995066606 (/A m M REDDY & Co., S iNnp1a Chartered Accountants Mobile: 984 40 82 27 72 16 551 57 M MR Lion Corp, 4th Floor, HSR Eden, Road No. 2, Banjara Hills, Hyderabad — 500034.TS. E-mail: mmreddyandco@gmail.com LIMITED REVIEW REPORT The Board of Directors, Sangam Health Care Products Limited We have reviewed the accompanying statement of Un-Audited Financial Results of Sangam Health Care Products Limited for the guarter ended 30t June 2026 attaching herewith, being submitted by the company pursuant to the requirements of Regulation 33 of the SEBI (Listing obligations and disclosure Requirements) Regulations, 2015, as amended. The preparation of the statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (Ind AS 34) prescribed under Section 133 of the companies Act, 2013 read with Rule 3 of Companies (Indian Accounting Standard) Rules, 2015 is the responsibility of the company management and has been approved by the Board of Directors of the Company. Our Responsibility is to express a conclusion on the statement based on our review. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, Review of Interim Financial information performed by the Independent auditor of the Entity issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement, prepared in accordance with the recognition and measurement princip [Showing first 8,000 characters — download PDF for full document]